6 - Does a sponsor have any recourse if it designed the trial badly, leading to misleading results? Or is its remedy really to design a better trial and publicize that one?
This is a hard one. I anticipate that at least initially only Good People will be using this protocol. These are people who spent a lot of time creating something to (hopefully) make the world better. Not cool to screw them if they make a mistake, or if v1 isn’t as awesome as anticipated.
A related question is: what can we do to help a company that has demonstrated its effectiveness?
This is a hard one. I anticipate that at least initially only Good People will be using this protocol. These are people who spent a lot of time creating something to (hopefully) make the world better. Not cool to screw them if they make a mistake, or if v1 isn’t as awesome as anticipated.
A related question is: what can we do to help a company that has demonstrated its effectiveness?
This is exactly the moral hazard companies face with the normal procedure too.
The main advantage I see is that the webapp approach is much cheeper allowing companies t do it early thus reducing the moral hazard.